Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study

Autor: Elles J. T. M. van der Louw, Joanne F. Olieman, Patricia M. L. A. van den Bemt, Jacoline E. C. Bromberg, Esther Oomen-de Hoop, Rinze F. Neuteboom, Coriene E. Catsman-Berrevoets, Arnaud J. P. E. Vincent

Publikováno v: Therapeutic Advances in Medical Oncology, Vol 11 (2019)

Background: High-grade glioma cells consume mainly glucose and cannot compensate for glucose restriction. Apoptosis may potentially occur under carbohydrate restriction by a ketogenic diet (KD). We explored the feasibility and safety of KD during sta

Externí odkaz: https://doaj.org/article/b7b3cfbde0924d59898548d1de011465

European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)

Autor: Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, Julia Furtner, Jaime Gallego Perez-Larraya, Roger Henriksson, Andreas F Hottinger, Benjamin Kasenda, Florence Lefranc, Alexander Lossos, Catherine McBain, Matthias Preusser, Patrick Roth, Roberta Rudà, Uwe Schlegel, Riccardo Soffietti, Carole Soussain, Martin J B Taphoorn, Valérie Touitou, Michael Weller, Jacoline E C Bromberg

Publikováno v: Neuro-Oncology, 25(1), 37-53. OXFORD UNIV PRESS INC
Neuro-Oncology, 25(1), 37-53. Oxford University Press

The management of primary central nervous system (PCNSL) is one of the most controversial topics in neuro-oncology because of the complexity of the disease and the limited number of controlled studies available. In 2021, given recent advances and the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a3e406f43f696db82b04fd70df9679
http://hdl.handle.net/1887/3503817

Efficacy and safety of peptide receptor radionuclide therapy with [

Autor: Noémie S, Minczeles, Eelke M, Bos, Reinoud C, de Leeuw, Johan M, Kros, Mark W, Konijnenberg, Jacoline E C, Bromberg, Wouter W, de Herder, Clemens M F, Dirven, Johannes, Hofland, Tessa, Brabander

Publikováno v: European journal of nuclear medicine and molecular imaging.

There is no evidence-based systemic therapy for patients with progressive meningiomas for whom surgery or external radiotherapy is no longer an option. In this study, the efficacy and safety of peptide receptor radionuclide therapy (PRRT) in patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0e48f728eb9f01a67e0753040b8e98ab
https://pubmed.ncbi.nlm.nih.gov/36454268

Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)

Autor: Charlotte Bronnimann, Antonio Silvani, Vassilis Golfinopoulos, François Ducray, Martin Bendszus, Michael Weller, Marc Sanson, Paul Clement, Felix Sahm, Riccardo Soffietti, Niklas Thon, Corneel Coens, Florence Lefranc, Josef Pichler, Christian Mawrin, Veronique Lorgis, Lucy Brazil, Matthias Preusser, Emilie Le Rhun, Elodie Vauleon, Jacoline E C Bromberg, Alison Cameron, Juan Manuel Sepúlveda, Jordi Bruna, Joanne Lewis, Alice Bonneville-Levard, Christine Marosi, Sarah Dumont, Maximilian J. Mair, Sara Erridge, Julia Furtner, Jaap C. Reijneveld, Philipp Sievers, Wolfgang Wick, Giuseppe Lombardi, Petter Brandal, Carmen Balana, Thierry Gorlia

Publikováno v: Neuro-Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Neuro Oncol
Preusser, M, Silvani, A, le Rhun, E, Soffietti, R, Lombardi, G, Sepulveda, J M, Brandal, P, Brazil, L, Bonneville-Levard, A, Lorgis, V, Vauleon, E, Bromberg, J, Erridge, S, Cameron, A, Lefranc, F, Clement, P M, Dumont, S, Sanson, M, Bronnimann, C, Balaná, C, Thon, N, Lewis, J, Mair, M J, Sievers, P, Furtner, J, Pichler, J, Bruna, J, Ducray, F, Reijneveld, J C, Mawrin, C, Bendszus, M, Marosi, C, Golfinopoulos, V, Coens, C, Gorlia, T, Weller, M, Sahm, F & Wick, W 2022, ' Trabectedin for recurrent WHO grade 2 or 3 meningioma : A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG) ', Neuro-Oncology, vol. 24, no. 5, pp. 755-767 . https://doi.org/10.1093/neuonc/noab243
Neuro-Oncology, 24(5), 755-767. Oxford University Press

Background No systemic treatment has been established for meningioma progressing after local therapies. Methods This randomized, multicenter, open-label, phase II study included adult patients with recurrent WHO grade 2 or 3 meningioma. Patients were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caa9ac3cf01f56f7912643d67ee32456
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4496

Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients

Autor: Martin J. van den Bent, Gavin Cull, Marion Smits, Samar Issa, Hakim C. Achterberg, Jacoline E C Bromberg, Max Beijert, Josée M. Zijlstra, Jeanette K. Doorduijn, Katerina Bakunina, Martin J B Taphoorn, Harry C. Schouten, Tatjana Seute, Matthijs van der Meulen, Esther J. J. Habets, Dieta Brandsma, Linda Dirven, Roelien H. Enting

Publikováno v: Neuro-Oncology, 23(8), 1315-1326. Oxford University Press
Neuro-Oncology, 23(8), 1315-1326. OXFORD UNIV PRESS INC
Neuro Oncol
Neuro-oncology, 23(8), 1315-1326. Oxford University Press
van der Meulen, M, Dirven, L, Habets, E J J, Bakunina, K, Smits, M, Achterberg, H C, Seute, T, Cull, G, Schouten, H, Zijlstra, J M, Brandsma, D, Enting, R H, Beijert, M, Taphoorn, M J B, van den Bent, M J, Issa, S, Doorduijn, J K & Bromberg, J E C 2021, ' Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: Results from the HOVON 105/ALLG NHL 24 randomized controlled trial ', Neuro-Oncology, vol. 23, no. 8, pp. 1315-1326 . https://doi.org/10.1093/neuonc/noab021

Background To analyze the effect of treatment on neurocognitive functioning and the association of neurocognition with radiological abnormalities in primary central nervous system lymphoma (PCNSL). Methods One hundred and ninety-nine patients from a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88304e0b91e48d1ebefb3d9b24ccf859
https://doi.org/10.1093/neuonc/noab021